A Long QT Mutation Substitutes Cholesterol for Phosphatidylinositol-4,5-Bisphosphate in KCNQ1 Channel Regulation

Fabien C. Coyan; Fayal Abderemane-Ali; Mohamed Yassine Amarouch; Julien Piron; Jérôme Mordel; Céline S. Nicolas; Marja Steenman; Jean Mérot; Céline Marionneau; Annick Thomas; Robert Brasseur; Isabelle Baró; Gildas Loussouarn

doi:10.1371/journal.pone.0093255

Abstract

Introduction

Phosphatidylinositol-4,5-bisphosphate (PIP₂) is a cofactor necessary for the activity of KCNQ1 channels. Some Long QT mutations of KCNQ1, including R243H, R539W and R555C have been shown to decrease KCNQ1 interaction with PIP₂. A previous study suggested that R539W is paradoxically less sensitive to intracellular magnesium inhibition than the WT channel, despite a decreased interaction with PIP₂. In the present study, we confirm this peculiar behavior of R539W and suggest a molecular mechanism underlying it.

Methods and Results

COS-7 cells were transfected with WT or mutated KCNE1-KCNQ1 channel, and patch-clamp recordings were performed in giant-patch, permeabilized-patch or ruptured-patch configuration. Similar to other channels with a decreased PIP₂ affinity, we observed that the R243H and R555C mutations lead to an accelerated current rundown when membrane PIP₂ levels are decreasing. As opposed to R243H and R555C mutants, R539W is not more but rather less sensitive to PIP₂ decrease than the WT channel. A molecular model of a fragment of the KCNQ1 C-terminus and the membrane bilayer suggested that a potential novel interaction of R539W with cholesterol stabilizes the channel opening and hence prevents rundown upon PIP₂ depletion. We then carried out the same rundown experiments under cholesterol depletion and observed an accelerated R539W rundown that is consistent with this model.

Conclusions

We show for the first time that a mutation may shift the channel interaction with PIP₂ to a preference for cholesterol. This de novo interaction wanes the sensitivity to PIP₂ variations, showing that a mutated channel with a decreased affinity to PIP₂ could paradoxically present a slowed current rundown compared to the WT channel. This suggests that caution is required when using measurements of current rundown as an indicator to compare WT and mutant channel PIP₂ sensitivity.

Citation: Coyan FC, Abderemane-Ali F, Amarouch MY, Piron J, Mordel J, Nicolas CS, et al. (2014) A Long QT Mutation Substitutes Cholesterol for Phosphatidylinositol-4,5-Bisphosphate in KCNQ1 Channel Regulation. PLoS ONE 9(3): e93255. https://doi.org/10.1371/journal.pone.0093255

Editor: Alexander G. Obukhov, Indiana University School of Medicine, United States of America

Received: June 11, 2013; Accepted: March 3, 2014; Published: March 28, 2014

Copyright: © 2014 Coyan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by the Agence Nationale de la Recherche (ANR-05-JCJC-0160-01), the AFMTéléthon, and a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (GL). FCC and FA-A were recipients of a grant from the French Ministère de la Recherche. FA-A was supported by the Fondation d'entreprise Genavie. JP was supported by the Association Française contre les Myopathies. CSN was supported by the INSERM (poste d'accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Cholesterol regulates several ion channels, and changes in membrane cholesterol levels provoke various effects depending on the channel type (reviewed in [1], [2]). Regarding inwardly rectifying K⁺ channels (Kir), cholesterol effects have been studied in detail. Effects of cholesterol increase or depletion vary among families and even among channels of the same family. Similarly to Kir channels, functional effects of cholesterol on voltage-gated (Kv) channel activity are highly variable: an increase in Kv2.1 current in Drosophila neurons [3] and a suppression of the same current in mammalian pancreatic β-cells [4]. Adding more complexity, effects on the cardiac potassium channel KCNQ1 are variable depending on the drug used to decrease cholesterol levels [5], [6]. More specifically, Probucol - known as a cholesterol depleting agent - is able to decrease the coexpressed KCNE1/KCNQ1 current amplitude [5] without decreasing cholesterol levels in CHO-K1 [6]. Simvastatin and triparanol are more specific since their main effects (activation kinetics) are similar and correlated to a cholesterol decrease. Clearly, cholesterol effects on KCNQ1 channels remain to be studied in more detail.

Phosphatidylinositol-4,5-bisphosphate (PIP₂) is abundant in cholesterol-rich membrane domains [7]. The mechanisms by which PIP₂ regulates several channels, including KCNQ1, have been studied in much greater detail than the mechanism of their regulation by cholesterol [8]–[16]. PIP₂ is a minor acidic membrane lipid found primarily in the inner leaflet of the plasma membrane. It has been shown to be a necessary cofactor for a wide variety of ion channels and transporters [17]. In Kir and Kv channels, several stimuli impact channel activity by decreasing available PIP₂ or modulating channel-PIP₂ interactions [8], [9], [18]–[20]. Consistent with PIP₂ regulating channel activities, mutations that impair channel-PIP₂ interactions play a crucial role in channelopathies. Regarding KCNQ1, we have shown that type 1 long QT (LQT1) syndrome can be associated with a decrease in KCNQ1-PIP₂ interactions provoked by mutations in the S4–S5 linker (R243H) and in the C-terminal domain CTD (R539W and R555C) [10]. This has since been confirmed for mutations R539W and R555C [11], [12].

In previous studies, PIP₂ sensitivity of the KCNQ1 mutants R243H, R539W and R555C was determined by using the soluble short acyl chains analog diC8-PIP₂ [10]. Since then, PIP₂-regulated Kv11.1 channels have been shown to be insensitive to diC8-PIP₂ [21], suggesting that channel affinity for PIP₂ and diC8-PIP₂ might be quite different. Moreover, the R539W behavior seems paradoxical since, in COS-7 cells, this mutant was shown to be less sensitive than WT to intracellular Mg²⁺, which decreases PIP₂ availability through masking its negative charges [10]. In general, any mutation that reduces channel affinity to PIP₂ provokes an increased inhibition by Mg²⁺ [18]. Hence, we set out to use other approaches to further study the PIP₂ affinity of KCNQ1 mutant channels in the presence of KCNE1. We measured the kinetics of Mg²⁺-, wortmannin- and Ci-VSP-induced current rundown and confirmed a decreased PIP₂ affinity for two of the three mutants. To our surprise, for the third mutant (R539W) the current is running down more slowly when available PIP₂ is decreased. We therefore hypothesized that the KCNQ1-R539W mutation leads to the stabilization of an open-pore conformation shortcutting the PIP₂ effect on the concerted opening. Using both modeling and functional analyses, we show for the first time that a mutation in the CTD domain shifts the channel interaction with PIP₂ to a preference for cholesterol.

In conclusion, our study shows that cholesterol affects the rundown of R539W but not of WT KCNE1-KCNQ1 channels, suggesting that cholesterol specifically stabilizes opening of R539W channels and decreases their need for PIP₂ to be open. Estimating a channel affinity to PIP₂ from the kinetics of the current rundown when PIP₂ decreases is an approach that has been commonly used. This study indicates that such an approach is not always relevant, since the mutation that disrupts the interaction with PIP₂ may stabilize the channel open state through another mechanism.

Methods

Cell culture and transfection

The African green monkey kidney-derived cell line COS-7 was obtained from the American Type Culture Collection (Rockville, MD, USA) and cultured in Dulbecco's modified Eagle's medium (GIBCO, Paisley, Scotland). Cells were transfected with plasmids (2 µg per 35 mm dish) complexed with Fugene-6 (Roche Molecular Biochemical) for giant-patch and ruptured-patch experiments, or Jet-PEI (Polyplus-Transfection) for permeabilized-patch experiments, according to the standard protocol recommended by the manufacturers. We used a construct of hKCNQ1 fused to hKCNE1 (KCNE1-KCNQ1) to prevent variability caused by a variable KCNE1/KCNQ1 expression ratio [10]. This type of construct is justified by the fact that the cardiac channel is generated by the assembly of 4 KCNQ1 and up to 4 KCNE1 subunits [22]. For giant-patch experiments, the relative DNA composition was 80% pCDNA3.1 plasmid containing the human WT or mutated KCNE1-KCNQ1 concatemer [10], [23] and 20% pEGFP coding for the green fluorescent protein (Clontech). For permeabilized-patch experiments testing the effects of osmolarity, relative DNA composition was 40% pCDNA3.1 KCNE1-KCNQ1 and 60% pEGFP. For permeabilized-patch experiments testing the PKA-dependent channel upregulation, relative DNA composition was 20% pCDNA3.1-KCNE1-KCNQ1, 40% pEGFP and 40% pCDNA3-yotiao (a kind gift of Dr Robert S. Kass, Department of Pharmacology, College of Physicians & Surgeons, Columbia University, New York, NY, USA). For ruptured-patch experiments testing the effects of Ci-VSP, relative DNA composition was 20% pCDNA3.1-KCNE1-KCNQ1, 70% pEGFP and 10% pRFP-C1-Ci-VSP (a kind gift of Dr Dominik Oliver, Institute of Physiology and Pathophysiology, Philipps-Universität Marburg, Marburg, Germany).

Electrophysiology

Forty-eight to seventy-two hours post-transfection, COS-7 cells were mounted on the stage of an inverted microscope and constantly perfused at a rate of 2 mL/min. Experiments were performed at room temperature for giant-patch and ruptured-patch configurations, or 35.0±1.0°C for permeabilized-patch configuration. Stimulation, data recording, and analysis were performed either by Acquis1 (Bio-logic Science Instruments, Claix, France) through an analog-to-digital converter (Tecmar TM100 Labmaster; Scientific Solution, Solon, OH, USA), or by pClamp10.4 through an analog-to-digital converter (Axon Digidata 1440, Molecular Devices, Sunnyvale, CA, USA). Electrodes were electrically connected to a patch-clamp amplifier (RK-400, Bio-logic Science Instruments, Claix, France).

For giant-patch experiments, the procedure has been described previously [24]. An ‘excision’ pipette, filled with the standard solution, was connected to a 10 ml syringe to apply suction for excision. Pipettes were pulled from borosilicate glass capillaries (glass type 8250; Garner Glass) on a vertical puller (P30; Sutter Instruments Co., Novato, CA, USA) and fire polished using a microforge (MF-83; Narishige, Japan) to reach 9 to 12 µm tip diameters for patch pipettes and around 15 µm for excision pipettes. Cells were continuously perfused with the standard solution. KCNE1-KCNQ1 currents were analyzed using a protocol consisting of depolarizing voltage steps of 1 s from a holding potential of −80 mV to +80 mV and then to −40 mV for 0.5 s, every 5 or 2 s. A microperfusion system allowed local application and rapid change of the different experimental solutions.

For permeabilized-patch experiments, micropipettes (tip resistance: 2–3 MOhms) were pulled from soda lime glass (Kimble; Vineland, New Jersey, USA). KCNE1-KCNQ1 currents were investigated with a protocol consisting of depolarizing voltage steps of 4 s from a holding potential of −80 mV to +80 mV and then to −40 mV for 1 s, every 7 s. To obtain the WT activation curve, the membrane potential was stepped, from a holding potential (−80 mV) to six voltage steps (−20 to 80 mV, with a 20 mV increment) and then stepped back to −40 mV, where tail currents are visible. To obtain the R539W activation curve, the membrane potential was stepped, from a holding potential (−80 mV) to six voltage steps (20 to 120 mV, with a 20 mV increment) and then stepped back to −40 mV, where tail currents are visible. Activation curves were fitted by a Boltzmann equation. KCNE1-KCNQ1 deactivation kinetics were obtained by a monoexponential fit.

For ruptured-patch experiments (Ci-VSP), the same pipettes as for permeabilized-patch experiments were used. KCNE1-KCNQ1 currents were investigated with a protocol consisting of depolarizing voltage steps of 2 s from a holding potential of −80 mV to +80 mV and then to −40 mV for 1 s, every 8 s.

Patch-clamp data are presented as mean ± SEM. Statistical significance of the observed effects was assessed by one-way ANOVA or Student's t-tests. Off-line analysis was performed using Acquis1, Clampfit and Microsoft Excel programs. Microsoft Solver was used to fit data by a least-square algorithm.

Solutions and drugs

For giant-patch experiments, the cells were perfused with a standard solution containing (in mmol/L): 145 KCl, 10 HEPES, 1 EGTA (pH 7.3 with KOH). The following solution (in mmol/L): 145 K-gluconate, 10 HEPES, 1 EGTA, (pH 7.3 with KOH) was used to perfuse the cell during K⁺ current measurements and to fill the patch pipette tip (the Cl⁻-containing solution was in contact with the Ag⁺/AgCl filament).

For permeabilized-patch experiments, the pipette (intracellular) solution had the following composition (in mmol/L): 145 KCl, 10 HEPES, 1 EGTA and 0.85 amphotericin B (pH 7.2 with KOH). The Tyrode superperfusion solution contained (in mmol/L): 145 NaCl, 4 KCl, 1 CaCl₂, 1 MgCl₂, 5 HEPES, 5 glucose (pH 7.4 with NaOH). The locally applied extracellular control solution (334 mosmol/L) contained (in mmol/L): 145 NaCl, 4 KCl, 1 CaCl₂, 1 MgCl₂, 5 HEPES, 5 glucose, 20 mannitol (pH 7.4 with NaOH). Hypoosmotic challenge (234 mosmol/L) was induced by a decrease of NaCl from 145 mmol/L to 86 mmol/L and an increase of mannitol from 20 mmol/L to 39 mmol/L. In hyperosmotic solution (434 mosmol/L) NaCl was increased to 205 mmol/L and mannitol was decreased to 0.9 mmol/L. We looked at the effect of osmolarity on R539W and WT channels in the same set of experiments. The effects on the WT channel have been previously published and serve as a positive control [14]. For ruptured-patch experiments, the pipette (intracellular) solution had the following composition (in mmol/L): 145 KCl, 10 HEPES, 1 EGTA and 1 MgCl₂ (pH 7.2 with KOH). Cells were perfused with Tyrode solution.

Available PIP₂ was decreased by three ways: in the permeabilized-patch configuration, PIP₂ was decreased by application of 10 µmol/L wortmannin [16], [25], [26]. In giant-patch experiments, available PIP₂ was decreased by direct application of 1.1 mmol/L free Mg²⁺ on the intracellular side of giant patches [14]. In ruptured-patch configuration, channels were coexpressed with the voltage-dependent phosphatase from Ciona intestinalis, Ci-VSP, allowing PIP₂ dephosphorylation [27], [28].

In channel PKA-dependent phosphorylation experiments, cells were exposed to a solution containing (in µmol/L) 400 cpt-cAMP, 10 forskolin and 0.2 okadaic acid. For cholesterol depletion experiments, two different approaches were used: one-hour pre-treatment of 2 mmol/L 2-hydroxypropyl-β-cyclodextrin in Tyrode solution at 37°C or twenty-four hour pre-treatment of 10 µmol/L triparanol [6] in 1 ml of the cell culture medium. Free magnesium activities in gluconate-containing solutions were calculated using software designed by G. L. Smith (University of Glasgow, Scotland), using stability constants [29].

Molecular Modeling

Peptides.

3D models of the WT and mutated sequence fragments, QQARKPYDV-R539-DVIEQYSQG and QQARKPYDV-W539-DVIEQYSQG, were calculated using Peplook [30]. Briefly, populations of 3D models are built from sequences using a boltzmanian stochastic procedure in which calculated populations are 3D models of lower energy. Models are all-atoms and their energies take into account all interactions between non-bound atoms with a cut-off of 20 Å. Energy terms are van der waals (Lennard-Jones), electrostatic (coulomb with an exponentially variable dielectric constant from 1 to 80 on a distance of 2 to 30 Å) and two hydrophobicity terms, one for intramolecular interactions and the second for solvent effect. The first term uses atomic transfer energy (Etr) and atom distances, the second one uses atom accessible atom surface area and atom Etr in the corresponding solvent, as previously described [30]. The best model is named the Prime and the next 98 models of low energy are also sorted to form the peptide population. The populations are clustered around lead models on the basis of backbone RMSd<1 Å.

Lipids.

3D models of lipids were calculated by the same procedure as PepLook but using a dataset of rotation angles covering the 360° rotation possibilities by steps of 7.5°.

Impala.

The Prime models of each peptide and lipid were individually tested across the water/membrane slab named IMPALA to define their best position [31]. IMPALA is a continuous restraint potential mimicking membrane hydrophobicity, charge density and fluidity properties with respect to water. The mass centre of each model was set at 101 different levels i.e. every angstrom from −50 to +50 from the membrane centre, across the slab. At each position, the restraint potential of 10,000 different orientations (rotations in the x/y plane of the membrane) was calculated and used to select the best position. In the figures, colored grids indicate different membrane interfaces: pink, the water/membrane interface; purple, the polar head/acyl chain interface of lipids; yellow, the membrane centre.

Molecule hydrophobicity and charge.

To illustrate molecule hydrophobicity and charge, we used MHP (Molecular Hydrophobicity Potential) and MEP (Molecular Electrostatic Potential). MHP and MEP are three-dimensional plots of the hydrophobicity and electrostatic isopotential surface of a molecule, respectively [32]. In the MHP plots, surfaces joining all points of ±0.1 kcal are drawn; green for the hydrophilic surface, brown for the hydrophobic surface. In the MEP plots, surfaces joining all points of ±10 kcal are drawn; blue for the negatively charged surface, red for the positively charged surface.

Results

R539W KCNE1-KCNQ1 is poorly sensitive to PIP₂ decrease

To obtain a quantification of channel PIP₂ sensitivity, addition of soluble diC8-PIP₂ is commonly used [8]. In a previous study, we used this approach to determine the PIP₂ sensitivity of three LQT1-associated KCNQ1 channels containing the R243H, R539W or R555C mutation [10]. However, this approach may be limited because, for some channels, the maximum effect of short-chain PIP₂ is less than that of PIP₂, suggesting a lower affinity [33] and/or a contribution of the acyl chain to the channel-PIP₂ interaction. As an extreme example, the Kv11.1 channel is sensitive to PIP₂ but not to diC8-PIP₂ [21]. These new results prompted us to use alternative methods to confirm the decreased PIP₂ sensitivity of R243H, R539W and R555C mutant channels. We used three different approaches: Extracellular wortmannin effects on whole-cell currents, intracellular magnesium effects on excised-patch currents and Ci-VSP-coexpression effects on whole-cell currents [10], [18], [27], [28], [34].

In the permeabilized-patch configuration, we monitored the activity of WT and mutant KCNE1-KCNQ1 channel currents during application of 10 µmol/L wortmannin that blocks the PI4-kinase required for PIP₂ synthesis. Current density measured at the end of the depolarizing step (+80 mV) was monitored every 7 s and normalized to the current value measured before wortmannin application (time 0). Wortmannin application led to a gradual decrease of WT KCNE1-KCNQ1 channel activity, called rundown (Figure 1A and 1B). This rundown is also significant for the R243H and R555C, but not for the R539W channel (Table S1 in File SI). In order to compare the rundown kinetics in the different conditions, the relative current amplitude after 63 s in 10 µmol/L wortmannin was calculated. Rundown was accelerated for R243H and R555C mutants as compared to WT (Figures 1B and 1C), confirming a decreased PIP₂ sensitivity. Relative current amplitude after 63 s in 10 µmol/L wortmannin was 0.88±0.03 (n = 7) for WT channel, and 0.77±0.04 (n = 5; P<0.05) and 0.76±0.06 (n = 5; P<0.05) for R243H and R555C mutants, respectively. Most importantly, despite the lower affinity of short-chain PIP₂ for R539W, the decrease of PIP₂ levels caused by wortmannin application had no effect on this mutant channel activity (Figures 1B and 1C).

Download:

Figure 1. R539W is insensitive to wortmannin.

A, representative permeabilized-patch current recordings of WT or mutant channels measured before or after a 63-s wortmannin application (10 µmol/L), and during the voltage-clamp protocol shown. Start-to-start interval = 7 s. B, relative current amplitude of WT or mutant channels measured at the end of the depolarizing step (+80 mV), plotted against time. Current values are normalized to the current level measured before wortmannin application (time 0). These experiments were performed at 35°C in the permeabilized-patch configuration. In this configuration, it has been shown that there is no spontaneous current rundown [24]. C, mean relative current amplitude of WT or mutant channels measured after a 63-s wortmannin application (n = 5–7). *p<0.05, versus WT.

https://doi.org/10.1371/journal.pone.0093255.g001

We tried to decrease PIP₂ intracellular levels to a higher extent, in an attempt to decrease R539W channel activity. To do that, we used intracellular Mg²⁺, which is known to mask PIP₂ negative charges [35]. We recorded WT and mutant channels activities during 1.1-mmol/L free Mg²⁺ application using the excised-patch configuration (Figure 2, Table S2 in File SI). As previously shown, Mg²⁺ application led to a gradual decrease of WT KCNE1-KCNQ1 channel activity (Figure 2A and 2B; τ = 18±3 s, n = 12). R243H and R555C currents decreased faster than that of WT, as during wortmannin application (Figure 2B and 2C; R243H, τ = 6.3±1.3 s, P<0.01 and R555C, τ = 4.7±0.5 s; n = 10–12, P<0.001 as compared to WT). Conversely, the R539W channel current ran down more slowly than the WT (τ = 60±22 s; n = 8; P<0.05).

Download:

Figure 2. R539W is poorly sensitive to intracellular magnesium.

A, representative giant-patch current recordings of WT or mutant channels measured after 5 and 25-s Mg²⁺ application (1.1 mmol/L free Mg²⁺), and during the voltage-clamp protocol shown. Start-to-start interval = 5 s. B, relative tail-current amplitude (measured at −40 mV) of WT or mutant channels after a depolarization to +80 mV, plotted against time. Current values are normalized to the current level measured before magnesium application (time 0). C, rundown time constant (τ) of WT and mutant channel currents (n = 8–12). *p<0.05, **p<0.01, ***p<0.001 versus WT.

https://doi.org/10.1371/journal.pone.0093255.g002

To confirm these results, we depleted PIP₂ by coexpressing the channels with the voltage-dependent phosphatase Ci-VSP, which is known to dephosphorylate PIP₂ under membrane depolarization [27]. Ci-VSP activation led to a gradual decrease of WT KCNE1-KCNQ1 channel activity (Figure 3A and 3B). As a negative control, the WT KCNE1-KCNQ1 channel was expressed without Ci-VSP and no current rundown was observed (Figure 3, Table S3 in File SI). Tail current density measured at −40 mV was monitored and normalized to the current value measured at time 0. The relative current amplitude after 64 s of Ci-VSP activity was calculated. Rundown was accelerated for R243H mutant as compared to WT (Figure 3B), confirming a decreased PIP₂ sensitivity. The relative current amplitude after 64 s of Ci-VSP activity was 0.35±0.04 (n = 11) and 0.21±0.02 (n = 6; P<0.05) for WT and R243H, respectively. When coexpressed with Ci-VSP, the R555C mutant channel had a very low current density (at time 0, I_tail = 0.16±0.08 pA/pF, p<0.001, n = 18) as compared to the mutant channel activity without Ci-VSP coexpression (I_tail = 4.27±1.64 pA/pF, n = 4). Such a Ci-VSP coexpression had no effect on the WT current density (I_tail = 13.4±7.64 pA/pF, n = 7 and I_tail = 25.4±6.15 pA/pF, n = 11 without and with Ci-VSP respectively, N.S.). Consistent with the lower affinity of the R555C mutant to diC8-PIP₂ [10], these results suggest that Ci-VSP has enough basal activity (i.e. without any depolarization to +80 mV) to decrease membrane-PIP₂ levels and that such a basal PIP₂ decrease is able to affect the R555C channel current density without any effect on the WT channel. In contrast, the decrease of PIP₂ levels caused by Ci-VSP activation had no effect on R539W channel activity (normalized I at 64 s = 0.99±0.06, n = 9, p<0.001 versus WT; Figure 3C).

Download:

Figure 3. R539W is insensitive to Ci-VSP.

A, representative ruptured-patch current recordings of WT or mutant channels coexpressed with the voltage-dependent membrane phosphatase, Ci-VSP, at the first (t = 0 s) and 9^th (t = 64 s) step of depolarization. These currents were measured during the voltage-clamp protocol shown. Start-to-start interval = 8 s. The +80-mV depolarization also allows Ci-VSP activation. B, relative tail-current amplitude (measured at −40 mV) of WT or mutant channels after a depolarization to +80 mV, plotted against time. Current values are normalized to the current amplitude measured before Ci-VSP activation (time 0). C, mean relative current amplitude of WT or mutant channels measured after a 64-s Ci-VSP activation (n = 6–11). *p<0.05, ***p<0.001 versus WT. ^§R555C already ran down before Ci-VSP activation, due to basal Ci-VSP activity, it is thus assimilated to 0 (n = 18). WT condition without Ci-VSP is shown in (B) and (C).

https://doi.org/10.1371/journal.pone.0093255.g003

These three different approaches show that, contrary to R243H and R555C mutants, R539W is much less sensitive to variation in PIP₂ levels than WT. A priori, the results are inconsistent with the similar sensitivity of R539W and R555C to diC8-PIP₂ observed previously [10]. The impaired Mg²⁺, wortmannin and Ci-VSP effects on R539W channel rundown questioned the validity of these approaches in the evaluation of PIP₂ sensitivity. We will address, later in this article, why the R539W channel is less sensitive to PIP₂ variation than WT.

R539W is insensitive to osmolarity

We then studied the R539W channel response to a physiological range of PIP₂ variation, by varying extracellular osmolarity. We previously showed that switching from hyperosmolar to hypoosmolar extracellular solution leads to an increase in available membrane PIP₂, provoking an increase in the WT KCNE1–KCNQ1 current density, a shift of the activation curve towards negative potentials and slower deactivation kinetics (Figure 4A, 4C and [14]). During the same set of experiments, we measured R539W channel current in isoosmolar (334 mosmol.L⁻¹), hypoosmolar (234 mosmol.L⁻¹, 70% of control osmolarity) and hyperosmolar extracellular solutions (434 mosmol.L⁻¹, 130% of control osmolarity; cf. Methods). Tail current density (measured after a +120-mV depolarization), half-activation potential and time constant of deactivation at −40 mV (τ_deact) were changed neither by switching from isoosmolar to hypoosmolar condition, nor by switching from isoosmolar to hyperosmolar condition (Figure 4B and 4D). This lack of R539W channel osmoregulation is supporting the idea that the mutant is much less sensitive to variations in PIP₂ levels than the WT channel.

Download:

Figure 4. R539W is insensitive to osmolarity.

A, B, superimposed representative permeabilized-patch recordings of WT (A) and R539W (B) KCNE1-KCNQ1 concatemer currents, respectively, measured in hyper-, iso- and hypoosmotic conditions using the voltage protocol shown in the insert. C, D, averaged tail-current density (in pA/pF), V_0.5 (in mV) and τ_deact (in ms) measured at −40 mV after a depolarization step to +80 mV for WT (C) and +120 mV for R539W (D) channel, in hyperosmotic (hyper), control (iso), and hypoosmotic solutions (hypo) (n = 10); same voltage protocol as in A. *p<0.05, ***p<0.001 (one-way ANOVA for repeated measures). Protocol and experimental conditions are similar to those used in our previous study analyzing the osmoregulation of KCNE1-KCNQ1 [14].

https://doi.org/10.1371/journal.pone.0093255.g004

R539W is as sensitive to PKA as WT KCNE1-KCNQ1

For some Kir channels, it has been established that phosphorylation by PKA increases their interactions with PIP₂ [9], [19]. Several studies have shown that KCNQ1 activity is regulated by PKA-dependent phosphorylation [36]–[38] and two studies suggested that the PKA-dependent phosphorylation of KCNQ1 increases its interaction with PIP₂ [9], [11]. If so, PKA should have less impact on R539W KCNE1-KCNQ1 current since R539W is less sensitive to PIP₂ variation. To test this idea, cells expressing KCNQ1, KCNE1 and the PKA-anchoring protein yotiao, were exposed to a solution containing (in µmol/L) 400 cpt-cAMP, 10 forskolin and 0.2 okadaic acid. Tail current density after a 1-s depolarization to +80 mV was measured in the permeabilized-patch configuration. cAMP had a similar effect on normalized tail currents of the WT and of the R539W channel (Figure 5; WT, 1.45±0.11 and R539W, 1.63±0.14; n = 12–13), indicating that the R539W mutant channel is as sensitive to PKA-dependent phosphorylation as the WT channel. Therefore, PKA regulation of KCNE1-KCNQ1 channel does not seem to act through a modulation of channel-PIP₂ interaction, which is consistent with the recent publication of Li et al, where phospho-mimetic mutations do not affect PIP₂ dependent rundown [12].

Download:

Figure 5. R539W is sensitive to PKA.

A, representative permeabilized-patch current recordings of WT or R539W channels (co-transfected with yotiao) measured during the voltage-clamp protocol shown. B, mean time course of channel activation by 400 µM cpt-cAMP, 10 µM forskolin and 0.2 µM okadaic acid (cAMP) for WT or R539W KCNE1-KCNQ1 concatemer channel tail currents measured at −40 mV after a 1 s depolarization to +80 mV and normalized to the current value before cAMP application (n = 12–13).

https://doi.org/10.1371/journal.pone.0093255.g005

Hypothesis on the molecular basis of the low sensitivity to PIP₂ variation of R539W

R539W and R555C mutants have fully-activated current amplitude similar to the WT channel [10], supporting the conclusion that they are similarly expressed, correctly folded, and fully processed to the cell membrane. R539W and R555C mutants have similar sensitivity to diC8-PIP₂ on one hand [10], but different responses to a decrease in membrane PIP₂ on the other hand (Figures 1, 2 and 3). Since a decrease in membrane PIP₂ closes the WT channel [13], our data indicate that the R539W channel is steadily open and poorly sensitive to membrane PIP₂ variation. Thus, R539W open state is not or less dependent on a direct or indirect interaction with PIP₂, as compared to WT.

To better understand the mechanism by which R539W is desensitized to variations in PIP₂ levels, we used molecular modeling to analyze the structure of the WT and mutant QQARKPYDV-R/W539-DVIEQYSQG fragments of the KCNQ1 C-terminus and their potential interaction with the membrane bilayer. In the absence of a full 3D model of the channel, only partial models were used to reach a working hypothesis.

Three dimensional structures of the fragments were calculated with PepLook [30]. For both fragments the 99 lower energy models were sorted and compared. For the WT sequence, the 99 models had a similar conformation i.e. a β-extended polar hairpin. R539 was located in the U-turn (Figure 6B). Models were clustered into three leads on the basis of RMSd less than 1 Å (Figure 6A). Leads were stabilized by aromatic (Y536/Y545) side chain interactions or by NH…π and NH…O H-bonds but mainly by side chain (R533-E543 and/or K534-D540) salt bridges. Of note, mutations of R533 and E543 are associated with LQT1 [39], consistent with their role in the hairpin structure stabilization. The lead models were polar structures with a mean hydrophobic to hydrophilic accessible surface ratio of 0.73±0.20 (Figure 6C). Because of its hydrophilicity, the fragment should map to the channel protein surface rather than in its core, being accessible to external partnership. In addition, due to its high content in positively-charged residues (R533, K534 and R539) and especially to the fact that R539 was accessible in all models, the fragment might be able to interact with negative charges of membrane phospholipids. As a basis for this hypothesis, we found that the best position of the WT fragment models was to be adsorbed on the membrane surface, with R539 diving in the interface (Figure 7A). In that position, what could be the R539 membrane partner? In Figure 7D, we show the optimal positions of PIP₂, cholesterol and DOPC in the same membrane slab. The depth of insertion of the WT fragment models argues for a possible interaction of R539 with the C = O moiety of PIP₂ (Figure 7D–7F).

Download:

Figure 6. PepLook models of the 19-aa sequence surrounding R539 and W539.

The sequences QQARKPYDVR539DVIEQYSQG and QQARKPYDVW539DVIEQYSQG were used to calculate amphipathic 3D structure models in water. A, D, the 99 PepLook models of low energy were clustered into three WT (A) and four R539W (D) lead models on the basis of backbone RMSd<1 Å. Ribbon structures of these lead models are fitted in (A and D) demonstrating their large similarity. B, E best models (Prime), with R539 in CPK for the WT fragment (B) and W539 in CPK for the mutant fragment (E). Both residues are protruding in a pin loop-like structure. C, F, hydrophobicity profiles of the WT and R539W Primes are visualized by the hydrophobic (brown) and hydrophilic (green) isopotential surface (+0.1 kcal/mol) around the molecule. The MHP profiles demonstrate, first, the rather important hydrophilicity of the models, and second, that changing R to W, transforms a very polar protuberance to an apolar one.

https://doi.org/10.1371/journal.pone.0093255.g006

Download:

Figure 7. Relative position of a series of molecules in the membrane.

All molecules are shown at their optimal position in the IMPALA slab after they were systematically tested at every Å across a water/membrane continuous layer. In all plots, the yellow grid represents the membrane center; the purple grid, the averaged lipid head/acyl chain interface, and the pink grid the averaged lipid/water interface. A, PepLook model of the WT (left) and R539W (right) peptides. In both cases, residue 539 is imbedded in the membrane. B, MHP (Molecular Hydrophobicity Potential) profiles of fragments. R539 is responsible for a large hydrophilic (green) protuberance, whereas W539 is a hydrophobic (brown) protuberance in the membrane. C, MEP (molecular electrostatic profile) of the same molecules showing the e-attractivity of the R539 protuberance. D, E and F, same as in A, B and C except that molecules are, from left to right, an extended fluid form of PIP₂, cholesterol, and a fluid form of DOPC. They highlight the relative position of PIP₂ and peptides and the fact that the more hydrophobic cholesterol is embedded in the membranes.

https://doi.org/10.1371/journal.pone.0093255.g007

For the R539W mutant, changing R to W changed the 3D structure but not the extended conformation (Figure 6A compared with 6D). Four lead models were sorted (Figure 6D) and W539, like R539, was a structural protuberance. The hydrophobicity profiles of the WT and R539W models demonstrate that changing R to W decreased the hydrophilicity (Figure 6F to be compared with Figures 6C, 7B and 7C). The R539W mutant had a mean hydrophobic to hydrophilic accessible surface ratio of 0.81+0.10 supporting the conclusion that the fragment was still polar and that the R539 polar protuberance of the native fragment was now a W539 hydrophobic protuberance. The best position of the R539W mutant channel fragment in the membrane/water slab was the membrane interface similar to the WT fragment (Figures 7A–7C). Even though fragment positions are similar, their partners in the membrane should be different. The WT fragment could have a polar R-phospholipid interaction whereas the mutant fragment would more likely favor an interaction of the apolar W539 with a more hydrophobic partner.

Among natural membrane lipids, cholesterol has been implicated in direct interactions with some channels and in the regulation of their activities [40], [41]. Various studies have suggested that protein-cholesterol interactions implicate tryptophan [42], [43]. Interestingly, in another ion channel, a mutation of a cysteine to a tryptophan in a lipid-exposed position enhances the effect of cholesterol [42]. Tryptophan can interact with cholesterol in a rigid cycle-to-cycle hydrophobic fit stabilized by OH (cholesterol) - π (tryptophan cycle) or by NH (tryptophan cycle) - O (cholesterol) interactions if the two partners are at the same depth of insertion in the membrane. Our calculations indicate that the cholesterol polar head and tryptophan are at the same level in the membrane and thus justify the hypothesis that changing R539 to W could switch a polar R-PIP₂ interaction to a W-cholesterol interaction.

R539W interacts with membrane cholesterol

To test this hypothesis, we probed whether the decreased sensitivity of the R539W mutant to PIP₂ was associated with a gain in cholesterol sensitivity. We tried three different approaches: first, we measured the Mg²⁺-induced current rundown of the R539F KCNE1-KCNQ1 channel, phenylalanine being less hydrophobic and bulky than tryptophan and thus likely to be a less efficient membrane anchor than tryptophan. Second, we compared the effect of depleting the membrane cholesterol by 2-hydroxypropyl-β-cyclodextrin (cyclodextrin) on WT and R539W channel current [44]. Since cyclodextrin is not very specific, we used another way of depleting membrane cholesterol. We selected triparanol because it has been shown to decrease cholesterol in a similar model [6]. In all these approaches we measured the relative tail-current amplitude of WT and mutant channels after a depolarization to +80 mV, during 1.1-mmol/L free Mg²⁺ application in the giant-patch configuration.

As expected, the Mg²⁺-induced current rundown of the R539F mutant channel was faster than the rundown of the R539W mutant channel activity and as fast as the rundown of WT current (Figures 8A and 8B). This behavior is consistent with a lower anchoring of the F539 on the membrane as compared to that of W539. The fact that R539F mutant channel is not running down faster than WT suggests that phenylalanine still interacts with cholesterol although less than the tryptophan does.

Download:

Figure 8. Effect of intracellular magnesium on WT, R539W and R539F mutant channels, and after membrane cholesterol depletion.

A, C, E, relative tail-current amplitude (at −40 mV) of WT or mutant channels measured after a depolarization to +80 mV plotted against time during a 1.1 mmol/L free Mg²⁺ application on a giant-patch. Start-to-start interval = 2 s. Current values are normalized to the current level measured before magnesium application (time 0). Cholesterol depletion was induced by 1 hour of 2 mmol/L cyclodextrin (cyclo) or 24 hours of 10 µmol/L triparanol (tripa) pre-treatment. B, D, F, mean rundown time constant (τ) of WT and mutant channels (B), and with and without 2 mmol/L cyclodextrin (D, n = 9–13) or 10 µmol/L triparanol (F, n = 9–15). *p<0.05, **p<0.01 versus WT. DMSO in which triparanol was diluted (E and F) has an effect on rundown kinetics (τ = 15.4±1.6, n = 7 versus τ = 35.0±3.65, n = 15, without and with DMSO pre-treatment respectively, p<0.01).

https://doi.org/10.1371/journal.pone.0093255.g008

Second, we compared the Mg²⁺-induced rundown of the R539W mutant current without and with 2 mmol/L of cyclodextrin. As shown in Figures 8C and 8D, cyclodextrin pre-treatment accelerated the R539W rundown. Thus, when membrane cholesterol is decreased, the R539W channel is more sensitive to PIP₂ variation. In WT channels, only activation kinetics were affected by cholesterol depletion, as shown in Figure S1 in File SI and consistent with a previous work [6], but rundown was not affected (Figure 8C and 8D). As opposed to WT channels, R539W activation kinetics were not modified by cyclodextrin (Figure S1 in File SI).

Finally, we compared the Mg²⁺-induced rundown of the R539W mutant current without and with 10 µmol/L of triparanol. Like cyclodextrin, triparanol pre-treatment accelerated the R539W rundown without any significant change in the WT rundown (Figure 8E and 8F). These results confirm that the R539W channel is more sensitive to PIP₂ variation when membrane cholesterol is decreased. In addition, as for cyclodextrin, in WT channels, only activation kinetics were affected by the triparanol pre-treatment. In R539W mutant channels, activation kinetics were unchanged by the triparanol pre-treatment (Figure S2 in File SI), consistent with the results using cyclodextrin to deplete membrane cholesterol. These results reinforce the idea that interaction of cholesterol with WT and R539W channels is quite different.

Altogether, data from experiments manipulating the residue at position 539, and cholesterol levels in the membrane, are in agreement with the hypothesis that the tryptophan in position 539 interacts (or induces an interaction) with membrane cholesterol. This channel-cholesterol interaction might overrule the channel-PIP₂ interaction to stabilize the channel open-state.

Discussion

In previous studies, we have shown that KCNE1-KCNQ1 channel open-state is stabilized by PIP₂ and impairment of this stabilization by arginine neutralization at position 243, 539 or 555 in KCNQ1 is correlated with the long QT syndrome [10], [13]. For the three mutants, higher diC8-PIP₂ concentrations than for WT were needed to stabilize the open state after the channel activity had run down, suggesting a decrease in interaction with PIP₂ [10]. The R539W and R555C mutations are localized in the cytosolic C-terminus (CTD) [45]. The supposed interaction of arginines 539 and 555 with PIP₂ suggests that they are situated on the membrane-cytosol interface, which may be surprising since they are located in the middle of the distal half of the KCNQ1 cytosolic CTD [45]. In a recent crystallographic study, Hansen et al. described that PIP₂ mediates docking of the whole CTD to the transmembrane module and subsequent opening of the inner helix gate of the Kir2.2 channel [46]. Thereby, the KCNQ1 distal CTD might come close in order to interact with the membrane, via interactions such as R539-PIP₂ and R555-PIP₂, allowing the CTD to be in the vicinity of the pore domain for modulating its opening. However, further crystallographic studies should address this hypothesis.

In the present study, the most striking result was that decreasing endogenous PIP₂ has a very small effect on the open-state stability of the R539W mutant. R539W is paradoxically less sensitive to a decrease in PIP₂ than WT. This is in contrast with many channel mutations that reduce their affinity for PIP₂ or diC8-PIP₂ [47], [48], including the two other KCNQ1 mutations R243H and R555C. Here we suggest that the paradoxical behavior of R539W is due to the stabilizing effect of tryptophan-cholesterol interaction that replaces the arginine-PIP₂ interaction. Indeed, severe cholesterol depletion of the membrane restored the PIP₂ sensitivity of the channel. After cyclodextrin or triparanol pre-treatment, R539W rundown kinetics during Mg²⁺ application were restored to values similar to WT, suggesting that membrane cholesterol depletion abolished the R539W open pore stabilization, now only maintaining its open stabilization through other PIP₂-interacting residues (such as R243 and R555). It is important to note that - when expressed in Xenopus oocytes - R539W behaved exactly as R555C [12]. In that model, both excision-induced rundown and PIP₂ sensitivity were the same for R555C and R539W. This apparent inconsistency between models may be due to different cholesterol levels around the channel in X. oocytes versus COS-7 cells, with higher levels in the latter, slowing down R539W rundown.

For Kir4.1, Hibino and Kurachi showed that cyclodextrin abolishes the function of Kir4.1 channels in HEK293 cells [49]. One of the proposed mechanistic hypotheses suggests that cholesterol influences the conformation of Kir4.1 and activates it by specific protein-cholesterol interactions [49]. This hypothesis is supported by some studies performed on other channels. Singh et al. demonstrated a direct effect of cholesterol on the activity of KirBac1.1 [40]. They showed that changes in membrane fluidity could not account for the effects of the sterols on KirBac1.1 activity, and their data strongly pointed to a direct cholesterol-channel interaction. The present study is also supporting a direct and specific cholesterol-channel interaction.

We have previously reported that KCNE1-KCNQ1 activity is regulated by intracellular ATP in addition to PIP₂ [13]. More precisely, Li et al. recently showed that ATP binds to the cytosolic domain and promotes pore opening [50]. Since the patch-clamp experiments were performed without ATP in the intracellular solution, the gradual decrease of channel activity is probably the sum of the PIP₂- and the ATP-dependent channel rundown. This is especially true in giant-patch experiments, during which ATP is diffusing out of the patch very quickly. Even though the regulation of KCNQ1 by PIP₂ and by ATP concerns two distinct mechanisms [13], and distinct binding sites [51], there may be some interplay between both types of regulation. For instance, it has been shown that variations in intracellular ATP provoke variations in membrane PIP₂ levels [25], [52]. In that context, using R539W - which is much less PIP₂-sensitive - may reveal to what extent PIP₂-dependent rundown influences the ATP-dependent rundown.

KCNQ1 and KCNE1 localize in lipid rafts [53]–[55] as well as the G-protein-dependent machinery involved in β-adrenergic signaling [56]. From the literature, it appears that cholesterol may be involved in KCNQ1 expression levels and channel-complex trafficking [5], [57] and gating [6]. Here we show that cholesterol does not stabilize WT KCNE1-KCNQ1 channel opening per se. Substitution of R539 by W introduces a new sensitivity to acute cholesterol changes, possibly by favoring a direct binding of this residue to cholesterol, which is abundant in lipid rafts. In Kir2.1 channels, Epshtein et al. identified a specific region that plays a critical role in the sensitivity of these channels to cholesterol [58]. This region is in the CTD, consistent with the location of R539 in KCNQ1. Nonetheless, PIP₂ still regulates partially the R539W mutant, since in the presence of cholesterol, severe depletion of PIP₂ eventually induced open-state destabilization. This indicates that other PIP₂ interacting residues (such as R243 and R555) are still needed for channel opening. This severe depletion of PIP₂ allowed unmasking of the reduced diC8-PIP₂ sensitivity of the R539W mutant, since higher doses of diC8-PIP₂ are necessary to activate the channel [10].

We inferred the PIP₂ sensitivity of WT and mutated channels from the measurement of the rundown kinetics of the corresponding current during a decrease in available PIP₂.The decrease in PIP₂ was triggered using three common approaches: extracellular wortmannin application on permeabilized-patch configuration, intracellular Mg²⁺ application on excised-patch configuration, and Ci-VSP coexpression on ruptured-patch configuration [10], [18], [27], [28], [34]. Although the R539W mutant showed a decreased affinity to diC8-PIP₂ compared to WT [10], all these three approaches show that this mutant is less sensitive to a PIP₂ decrease, which would classically suggest a higher affinity to PIP₂. This peculiar behavior suggests that caution should be taken when using the current rundown in the evaluation of a channel PIP₂ affinity, because, in some cases (e.g. R539W), the mutation that disrupts the interaction with PIP₂ may stabilize the channel in the open state through another mechanism.

In conclusion, the present study shows that a channel mutation can induce or favor an interaction between the channel and a membrane component. We speculate that this PIP₂-independent tryptophan-cholesterol interaction is responsible for the difference in phenotypes observed for patients with long QT syndrome caused by R539W and R555C mutations of KCNQ1. Until now, both mutations were characterized by similar functional effects in cellular models, but the R555C mutation is associated with a ‘forme fruste’ of type 1 long QT syndrome [59] whereas R539W is associated with cardiac sudden death [60]. This difference could be caused by the drastic decrease of sensitivity of the R539W mutant to PIP₂ variation (cf wortmannin, Mg²⁺, osmolarity and Ci-VSP effects), and thus the poor sensitivity of the channel to signaling dependent on PLC-coupled receptors [61].

Supporting Information

File S1.

Supporting Information Figures and Tables. Figure S1, Effect of cyclodextrin on WT and R539W activation kinetics. A, Representative recording of a COS-7 cell transfected with WT or R539W KCNE1-KCNQ1 concatemer channel, without and with 1-hour pre-treatment by 2 mmol/L cyclodextrin. B and C, Mean +/− sem of WT and R539W activation tau from monoexponential fit of activation without and with cyclodextrin pre-treatment. * p<0.05. Figure S2, Effect of triparanol on WT and R539W activation kinetics. A, Representative recording of a COS-7 cell transfected with WT or R539W KCNE1-KCNQ1 concatemer channel, without and with 24-hour pre-treatment by 10 µmol/L triparanol. B and C, Mean +/− sem of WT and R539W activation tau from monoexponential fit of activation without and with triparanol pre-treatment. * p<0.05. Table S1, Wortmannin-induced rundown. Table S2, Magnesium-induced rundown. Table S3, Ci-VSP-induced rundown.

https://doi.org/10.1371/journal.pone.0093255.s001

(PDF)

Acknowledgments

We thank Béatrice Leray and Agnès Carcouët (INSERM, UMR 1087, Nantes) for expert technical assistance. We thank Flavien Charpentier (INSERM, UMR 1087, Nantes) for careful reading of the manuscript.

Author Contributions

Conceived and designed the experiments: AT RB IB GL J. Mérot. Performed the experiments: AT FCC FA-A MYA JP J. Mordel CSN MS CM GL. Analyzed the data: AT FCC FA-A MYA JP J. Mordel CSN MS CM GL. Wrote the paper: AT IB GL MYA JP FCC FA-A.

References

1. Levitan I, Fang Y, Rosenhouse-Dantsker A, Romanenko V (2010) Cholesterol and ion channels. Subcell Biochem 51: 509–549.
- View Article
- Google Scholar
2. Coyan FC, Loussouarn G (2013) Cholesterol regulation of ion channels: Crosstalk in proteins, crosstalk in lipids. Channels 7: 415–416.
- View Article
- Google Scholar
3. Gasque G, Labarca P, Darszon A (2005) Cholesterol-depleting compounds modulate K+-currents in Drosophila Kenyon cells. FEBS Lett 579: 5129–5134.
- View Article
- Google Scholar
4. Xia F, Gao X, Kwan E, Lam PPL, Chan L, et al. (2004) Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279: 24685–24691.
- View Article
- Google Scholar
5. Taniguchi T, Uesugi M, Arai T, Yoshinaga T, Miyamoto N, et al. (2012) Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation. J Cardiovasc Pharmacol 59: 377–386.
- View Article
- Google Scholar
6. Hihara T, Taniguchi T, Ueda M, Yoshinaga T, Miyamoto N, et al. (2013) Probucol and the cholesterol synthesis inhibitors simvastatin and triparanol regulate I ks channel function differently. Hum Exp Toxicol 32: 1028–1037.
- View Article
- Google Scholar
7. Pike LJ, Casey L (1996) Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271: 26453–26456.
- View Article
- Google Scholar
8. Zhang H, Craciun LC, Mirshahi T, Rohács T, Lopes CMB, et al. (2003) PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37: 963–975.
- View Article
- Google Scholar
9. Lopes CMB, Remon JI, Matavel A, Sui JL, Keselman I, et al. (2007) Protein kinase A modulates PLC-dependent regulation and PIP2-sensitivity of K+ channels. Channels (Austin) 1: 124–134.
- View Article
- Google Scholar
10. Park KH, Piron J, Dahimene S, Mérot J, Baró I, et al. (2005) Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome. Circ Res 96: 730–739.
- View Article
- Google Scholar
11. Matavel A, Medei E, Lopes CMB (2010) PKA and PKC partially rescue long QT type 1 phenotype by restoring channel-PIP2 interactions. Channels (Austin) 4: 3–11.
- View Article
- Google Scholar
12. Li Y, Zaydman MA, Wu D, Shi J, Guan M, et al. (2011) KCNE1 enhances phosphatidylinositol 4,5-bisphosphate (PIP2) sensitivity of IKs to modulate channel activity. Proc Natl Acad Sci USA 108: 9095–9100.
- View Article
- Google Scholar
13. Loussouarn G, Park KH, Bellocq C, Baró I, Charpentier F, et al. (2003) Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J 22: 5412–5421.
- View Article
- Google Scholar
14. Piron J, Choveau FS, Amarouch MY, Rodriguez N, Charpentier F, et al. (2010) KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines. J Physiol (Lond) 588: 3471–3483.
- View Article
- Google Scholar
15. Abderemane-Ali F, Es-Salah-Lamoureux Z, Delemotte L, Kasimova MA, Labro AJ, et al. (2012) Dual effect of phosphatidylinositol (4,5)-bisphosphate PIP(2) on Shaker K(+) [corrected] channels. J Biol Chem 287: 36158–36167.
- View Article
- Google Scholar
16. Suh BC, Hille B (2002) Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35: 507–520.
- View Article
- Google Scholar
17. Logothetis DE, Petrou VI, Adney SK, Mahajan R (2010) Channelopathies linked to plasma membrane phosphoinositides. Pflugers Arch 460: 321–341.
- View Article
- Google Scholar
18. Du X, Zhang H, Lopes C, Mirshahi T, Rohacs T, et al. (2004) Characteristic interactions with phosphatidylinositol 4,5-bisphosphate determine regulation of kir channels by diverse modulators. J Biol Chem 279: 37271–37281.
- View Article
- Google Scholar
19. Liou HH, Zhou SS, Huang CL (1999) Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism. Proc Natl Acad Sci USA 96: 5820–5825.
- View Article
- Google Scholar
20. Bian J, Cui J, McDonald TV (2001) HERG K(+) channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate. Circ Res 89: 1168–1176.
- View Article
- Google Scholar
21. Rodriguez N, Amarouch MY, Montnach J, Piron J, Labro AJ, et al. (2010) Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel. Biophys J 99: 1110–1118.
- View Article
- Google Scholar
22. Nakajo K, Ulbrich MH, Kubo Y, Isacoff EY (2010) Stoichiometry of the KCNQ1 - KCNE1 ion channel complex. Proc Natl Acad Sci USA 107: 18862–18867.
- View Article
- Google Scholar
23. Wang W, Xia J, Kass RS (1998) MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel. J Biol Chem 273: 34069–34074.
- View Article
- Google Scholar
24. Loussouarn G, Baró I, Escande D (2006) KCNQ1 K+ channel-mediated cardiac channelopathies. Methods Mol Biol 337: 167–183.
- View Article
- Google Scholar
25. Loussouarn G, Pike LJ, Ashcroft FM, Makhina EN, Nichols CG (2001) Dynamic sensitivity of ATP-sensitive K(+) channels to ATP. J Biol Chem 276: 29098–29103.
- View Article
- Google Scholar
26. Yasuda Y, Matsuura H, Ito M, Matsumoto T, Ding WG, et al. (2005) Regulation of the muscarinic K+ channel by extracellular ATP through membrane phosphatidylinositol 4,5-bisphosphate in guinea-pig atrial myocytes. Br J Pharmacol 145: 156–165.
- View Article
- Google Scholar
27. Murata Y, Iwasaki H, Sasaki M, Inaba K, Okamura Y (2005) Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor. Nature 435: 1239–1243.
- View Article
- Google Scholar
28. Rodriguez-Menchaca AA, Adney SK, Tang QY, Meng XY, Rosenhouse-Dantsker A, et al. (2012) PIP2 controls voltage-sensor movement and pore opening of Kv channels through the S4–S5 linker. Proc Natl Acad Sci USA 109: E2399–2408.
- View Article
- Google Scholar
29. Sillén LG, Martell AE, Bjerrum J (1964) Stability constants of metal-ion complexes. London: Chemical Society.
30. Thomas A, Deshayes S, Decaffmeyer M, Van Eyck MH, Charloteaux B, et al. (2006) Prediction of peptide structure: how far are we? Proteins 65: 889–897.
- View Article
- Google Scholar
31. Ducarme P, Rahman M, Brasseur R (1998) IMPALA: a simple restraint field to simulate the biological membrane in molecular structure studies. Proteins 30: 357–371.
- View Article
- Google Scholar
32. Brasseur R (1991) Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations. J Biol Chem 266: 16120–16127.
- View Article
- Google Scholar
33. Rohács T, Lopes C, Mirshahi T, Jin T, Zhang H, et al. (2002) Assaying phosphatidylinositol bisphosphate regulation of potassium channels. Meth Enzymol 345: 71–92.
- View Article
- Google Scholar
34. Liu B, Qin F (2005) Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J Neurosci 25: 1674–1681.
- View Article
- Google Scholar
35. Shyng SL, Nichols CG (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282: 1138–1141.
- View Article
- Google Scholar
36. Nicolas CS, Park KH, El Harchi A, Camonis J, Kass RS, et al. (2008) IKs response to protein kinase A-dependent KCNQ1 phosphorylation requires direct interaction with microtubules. Cardiovasc Res 79: 427–435.
- View Article
- Google Scholar
37. Walsh KB, Kass RS (1988) Regulation of a heart potassium channel by protein kinase A and C. Science 242: 67–69.
- View Article
- Google Scholar
38. Yazawa K, Kameyama M (1990) Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea-pig ventricular myocytes. J Physiol (Lond) 421: 135–150.
- View Article
- Google Scholar
39. Napolitano C, deGiuli L, Wilson J (n.d.) INHERITED ARRHYTHMIAS DATABASE. Available: http://www.fsm.it/cardmoc/.
40. Singh DK, Rosenhouse-Dantsker A, Nichols CG, Enkvetchakul D, Levitan I (2009) Direct regulation of prokaryotic Kir channel by cholesterol. J Biol Chem 284: 30727–30736.
- View Article
- Google Scholar
41. Bukiya AN, Belani JD, Rychnovsky S, Dopico AM (2011) Specificity of cholesterol and analogs to modulate BK channels points to direct sterol-channel protein interactions. J Gen Physiol 137: 93–110.
- View Article
- Google Scholar
42. Santiago J, Guzmàn GR, Rojas LV, Marti R, Asmar-Rovira GA, et al. (2001) Probing the effects of membrane cholesterol in the Torpedo californica acetylcholine receptor and the novel lipid-exposed mutation alpha C418W in Xenopus oocytes. J Biol Chem 276: 46523–46532.
- View Article
- Google Scholar
43. Carozzi AJ, Roy S, Morrow IC, Pol A, Wyse B, et al. (2002) Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3. J Biol Chem 277: 17944–17949.
- View Article
- Google Scholar
44. Atger VM, de la Llera Moya M, Stoudt GW, Rodrigueza WV, Phillips MC, et al. (1997) Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 99: 773–780.
- View Article
- Google Scholar
45. Wiener R, Haitin Y, Shamgar L, Fernández-Alonso MC, Martos A, et al. (2008) The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction. J Biol Chem 283: 5815–5830.
- View Article
- Google Scholar
46. Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477: 495–498.
- View Article
- Google Scholar
47. Lopes CMB, Zhang H, Rohacs T, Jin T, Yang J, et al. (2002) Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34: 933–944.
- View Article
- Google Scholar
48. Fan Z, Makielski JC (1997) Anionic phospholipids activate ATP-sensitive potassium channels. J Biol Chem 272: 5388–5395.
- View Article
- Google Scholar
49. Hibino H, Kurachi Y (2007) Distinct detergent-resistant membrane microdomains (lipid rafts) respectively harvest K(+) and water transport systems in brain astroglia. Eur J Neurosci 26: 2539–2555.
- View Article
- Google Scholar
50. Li Y, Gao J, Lu Z, McFarland K, Shi J, et al. (2013) Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks). Proc Natl Acad Sci USA 110: 18922–18927.
- View Article
- Google Scholar
51. Zaydman MA, Silva JR, Delaloye K, Li Y, Liang H, et al. (2013) Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening. Proc Natl Acad Sci USA 110: 13180–13185.
- View Article
- Google Scholar
52. Hilgemann DW, Ball R (1996) Regulation of cardiac Na+,Ca2+ exchange and KATP potassium channels by PIP2. Science 273: 956–959.
- View Article
- Google Scholar
53. Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, et al. (2007) Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116: 2913–2922.
- View Article
- Google Scholar
54. Roura-Ferrer M, Solé L, Oliveras A, Dahan R, Bielanska J, et al. (2010) Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface targeting. J Cell Physiol 225: 692–700.
- View Article
- Google Scholar
55. Balijepalli RC, Delisle BP, Balijepalli SY, Foell JD, Slind JK, et al. (2007) Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol. Channels (Austin) 1: 263–272.
- View Article
- Google Scholar
56. Yarbrough TL, Lu T, Lee HC, Shibata EF (2002) Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res 90: 443–449.
- View Article
- Google Scholar
57. Varga A, Bagossi P, Tözsér J, Peitl B, Szilvássy Z (2007) Effect of experimental hypercholesterolaemia on K+ channel alpha-subunit mRNA levels in rabbit hearts. Eur J Pharmacol 562: 130–131.
- View Article
- Google Scholar
58. Epshtein Y, Chopra AP, Rosenhouse-Dantsker A, Kowalsky GB, Logothetis DE, et al. (2009) Identification of a C-terminus domain critical for the sensitivity of Kir2.1 to cholesterol. Proc Natl Acad Sci USA 106: 8055–8060.
- View Article
- Google Scholar
59. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, et al. (1997) KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 96: 2778–2781.
- View Article
- Google Scholar
60. Chouabe C, Neyroud N, Richard P, Denjoy I, Hainque B, et al. (2000) Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc Res 45: 971–980.
- View Article
- Google Scholar
61. Jalili T, Takeishi Y, Walsh RA (1999) Signal transduction during cardiac hypertrophy: the role of G alpha q, PLC beta I, and PKC. Cardiovasc Res 44: 5–9.
- View Article
- Google Scholar

[ref1] 1. Levitan I, Fang Y, Rosenhouse-Dantsker A, Romanenko V (2010) Cholesterol and ion channels. Subcell Biochem 51: 509–549.
View Article
Google Scholar

[2] View Article

[3] Google Scholar

[ref2] 2. Coyan FC, Loussouarn G (2013) Cholesterol regulation of ion channels: Crosstalk in proteins, crosstalk in lipids. Channels 7: 415–416.
View Article
Google Scholar

[5] View Article

[6] Google Scholar

[ref3] 3. Gasque G, Labarca P, Darszon A (2005) Cholesterol-depleting compounds modulate K+-currents in Drosophila Kenyon cells. FEBS Lett 579: 5129–5134.
View Article
Google Scholar

[8] View Article

[9] Google Scholar

[ref4] 4. Xia F, Gao X, Kwan E, Lam PPL, Chan L, et al. (2004) Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279: 24685–24691.
View Article
Google Scholar

[11] View Article

[12] Google Scholar

[ref5] 5. Taniguchi T, Uesugi M, Arai T, Yoshinaga T, Miyamoto N, et al. (2012) Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation. J Cardiovasc Pharmacol 59: 377–386.
View Article
Google Scholar

[14] View Article

[15] Google Scholar

[ref6] 6. Hihara T, Taniguchi T, Ueda M, Yoshinaga T, Miyamoto N, et al. (2013) Probucol and the cholesterol synthesis inhibitors simvastatin and triparanol regulate I ks channel function differently. Hum Exp Toxicol 32: 1028–1037.
View Article
Google Scholar

[17] View Article

[18] Google Scholar

[ref7] 7. Pike LJ, Casey L (1996) Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271: 26453–26456.
View Article
Google Scholar

[20] View Article

[21] Google Scholar

[ref8] 8. Zhang H, Craciun LC, Mirshahi T, Rohács T, Lopes CMB, et al. (2003) PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37: 963–975.
View Article
Google Scholar

[23] View Article

[24] Google Scholar

[ref9] 9. Lopes CMB, Remon JI, Matavel A, Sui JL, Keselman I, et al. (2007) Protein kinase A modulates PLC-dependent regulation and PIP2-sensitivity of K+ channels. Channels (Austin) 1: 124–134.
View Article
Google Scholar

[26] View Article

[27] Google Scholar

[ref10] 10. Park KH, Piron J, Dahimene S, Mérot J, Baró I, et al. (2005) Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome. Circ Res 96: 730–739.
View Article
Google Scholar

[29] View Article

[30] Google Scholar

[ref11] 11. Matavel A, Medei E, Lopes CMB (2010) PKA and PKC partially rescue long QT type 1 phenotype by restoring channel-PIP2 interactions. Channels (Austin) 4: 3–11.
View Article
Google Scholar

[32] View Article

[33] Google Scholar

[ref12] 12. Li Y, Zaydman MA, Wu D, Shi J, Guan M, et al. (2011) KCNE1 enhances phosphatidylinositol 4,5-bisphosphate (PIP2) sensitivity of IKs to modulate channel activity. Proc Natl Acad Sci USA 108: 9095–9100.
View Article
Google Scholar

[35] View Article

[36] Google Scholar

[ref13] 13. Loussouarn G, Park KH, Bellocq C, Baró I, Charpentier F, et al. (2003) Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J 22: 5412–5421.
View Article
Google Scholar

[38] View Article

[39] Google Scholar

[ref14] 14. Piron J, Choveau FS, Amarouch MY, Rodriguez N, Charpentier F, et al. (2010) KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines. J Physiol (Lond) 588: 3471–3483.
View Article
Google Scholar

[41] View Article

[42] Google Scholar

[ref15] 15. Abderemane-Ali F, Es-Salah-Lamoureux Z, Delemotte L, Kasimova MA, Labro AJ, et al. (2012) Dual effect of phosphatidylinositol (4,5)-bisphosphate PIP(2) on Shaker K(+) [corrected] channels. J Biol Chem 287: 36158–36167.
View Article
Google Scholar

[44] View Article

[45] Google Scholar

[ref16] 16. Suh BC, Hille B (2002) Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35: 507–520.
View Article
Google Scholar

[47] View Article

[48] Google Scholar

[ref17] 17. Logothetis DE, Petrou VI, Adney SK, Mahajan R (2010) Channelopathies linked to plasma membrane phosphoinositides. Pflugers Arch 460: 321–341.
View Article
Google Scholar

[50] View Article

[51] Google Scholar

[ref18] 18. Du X, Zhang H, Lopes C, Mirshahi T, Rohacs T, et al. (2004) Characteristic interactions with phosphatidylinositol 4,5-bisphosphate determine regulation of kir channels by diverse modulators. J Biol Chem 279: 37271–37281.
View Article
Google Scholar

[53] View Article

[54] Google Scholar

[ref19] 19. Liou HH, Zhou SS, Huang CL (1999) Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism. Proc Natl Acad Sci USA 96: 5820–5825.
View Article
Google Scholar

[56] View Article

[57] Google Scholar

[ref20] 20. Bian J, Cui J, McDonald TV (2001) HERG K(+) channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate. Circ Res 89: 1168–1176.
View Article
Google Scholar

[59] View Article

[60] Google Scholar

[ref21] 21. Rodriguez N, Amarouch MY, Montnach J, Piron J, Labro AJ, et al. (2010) Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel. Biophys J 99: 1110–1118.
View Article
Google Scholar

[62] View Article

[63] Google Scholar

[ref22] 22. Nakajo K, Ulbrich MH, Kubo Y, Isacoff EY (2010) Stoichiometry of the KCNQ1 - KCNE1 ion channel complex. Proc Natl Acad Sci USA 107: 18862–18867.
View Article
Google Scholar

[65] View Article

[66] Google Scholar

[ref23] 23. Wang W, Xia J, Kass RS (1998) MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel. J Biol Chem 273: 34069–34074.
View Article
Google Scholar

[68] View Article

[69] Google Scholar

[ref24] 24. Loussouarn G, Baró I, Escande D (2006) KCNQ1 K+ channel-mediated cardiac channelopathies. Methods Mol Biol 337: 167–183.
View Article
Google Scholar

[71] View Article

[72] Google Scholar

[ref25] 25. Loussouarn G, Pike LJ, Ashcroft FM, Makhina EN, Nichols CG (2001) Dynamic sensitivity of ATP-sensitive K(+) channels to ATP. J Biol Chem 276: 29098–29103.
View Article
Google Scholar

[74] View Article

[75] Google Scholar

[ref26] 26. Yasuda Y, Matsuura H, Ito M, Matsumoto T, Ding WG, et al. (2005) Regulation of the muscarinic K+ channel by extracellular ATP through membrane phosphatidylinositol 4,5-bisphosphate in guinea-pig atrial myocytes. Br J Pharmacol 145: 156–165.
View Article
Google Scholar

[77] View Article

[78] Google Scholar

[ref27] 27. Murata Y, Iwasaki H, Sasaki M, Inaba K, Okamura Y (2005) Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor. Nature 435: 1239–1243.
View Article
Google Scholar

[80] View Article

[81] Google Scholar

[ref28] 28. Rodriguez-Menchaca AA, Adney SK, Tang QY, Meng XY, Rosenhouse-Dantsker A, et al. (2012) PIP2 controls voltage-sensor movement and pore opening of Kv channels through the S4–S5 linker. Proc Natl Acad Sci USA 109: E2399–2408.
View Article
Google Scholar

[83] View Article

[84] Google Scholar

[ref29] 29. Sillén LG, Martell AE, Bjerrum J (1964) Stability constants of metal-ion complexes. London: Chemical Society.

[ref30] 30. Thomas A, Deshayes S, Decaffmeyer M, Van Eyck MH, Charloteaux B, et al. (2006) Prediction of peptide structure: how far are we? Proteins 65: 889–897.
View Article
Google Scholar

[87] View Article

[88] Google Scholar

[ref31] 31. Ducarme P, Rahman M, Brasseur R (1998) IMPALA: a simple restraint field to simulate the biological membrane in molecular structure studies. Proteins 30: 357–371.
View Article
Google Scholar

[90] View Article

[91] Google Scholar

[ref32] 32. Brasseur R (1991) Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations. J Biol Chem 266: 16120–16127.
View Article
Google Scholar

[93] View Article

[94] Google Scholar

[ref33] 33. Rohács T, Lopes C, Mirshahi T, Jin T, Zhang H, et al. (2002) Assaying phosphatidylinositol bisphosphate regulation of potassium channels. Meth Enzymol 345: 71–92.
View Article
Google Scholar

[96] View Article

[97] Google Scholar

[ref34] 34. Liu B, Qin F (2005) Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J Neurosci 25: 1674–1681.
View Article
Google Scholar

[99] View Article

[100] Google Scholar

[ref35] 35. Shyng SL, Nichols CG (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282: 1138–1141.
View Article
Google Scholar

[102] View Article

[103] Google Scholar

[ref36] 36. Nicolas CS, Park KH, El Harchi A, Camonis J, Kass RS, et al. (2008) IKs response to protein kinase A-dependent KCNQ1 phosphorylation requires direct interaction with microtubules. Cardiovasc Res 79: 427–435.
View Article
Google Scholar

[105] View Article

[106] Google Scholar

[ref37] 37. Walsh KB, Kass RS (1988) Regulation of a heart potassium channel by protein kinase A and C. Science 242: 67–69.
View Article
Google Scholar

[108] View Article

[109] Google Scholar

[ref38] 38. Yazawa K, Kameyama M (1990) Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea-pig ventricular myocytes. J Physiol (Lond) 421: 135–150.
View Article
Google Scholar

[111] View Article

[112] Google Scholar

[ref39] 39. Napolitano C, deGiuli L, Wilson J (n.d.) INHERITED ARRHYTHMIAS DATABASE. Available: http://www.fsm.it/cardmoc/.

[ref40] 40. Singh DK, Rosenhouse-Dantsker A, Nichols CG, Enkvetchakul D, Levitan I (2009) Direct regulation of prokaryotic Kir channel by cholesterol. J Biol Chem 284: 30727–30736.
View Article
Google Scholar

[115] View Article

[116] Google Scholar

[ref41] 41. Bukiya AN, Belani JD, Rychnovsky S, Dopico AM (2011) Specificity of cholesterol and analogs to modulate BK channels points to direct sterol-channel protein interactions. J Gen Physiol 137: 93–110.
View Article
Google Scholar

[118] View Article

[119] Google Scholar

[ref42] 42. Santiago J, Guzmàn GR, Rojas LV, Marti R, Asmar-Rovira GA, et al. (2001) Probing the effects of membrane cholesterol in the Torpedo californica acetylcholine receptor and the novel lipid-exposed mutation alpha C418W in Xenopus oocytes. J Biol Chem 276: 46523–46532.
View Article
Google Scholar

[121] View Article

[122] Google Scholar

[ref43] 43. Carozzi AJ, Roy S, Morrow IC, Pol A, Wyse B, et al. (2002) Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3. J Biol Chem 277: 17944–17949.
View Article
Google Scholar

[124] View Article

[125] Google Scholar

[ref44] 44. Atger VM, de la Llera Moya M, Stoudt GW, Rodrigueza WV, Phillips MC, et al. (1997) Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 99: 773–780.
View Article
Google Scholar

[127] View Article

[128] Google Scholar

[ref45] 45. Wiener R, Haitin Y, Shamgar L, Fernández-Alonso MC, Martos A, et al. (2008) The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction. J Biol Chem 283: 5815–5830.
View Article
Google Scholar

[130] View Article

[131] Google Scholar

[ref46] 46. Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477: 495–498.
View Article
Google Scholar

[133] View Article

[134] Google Scholar

[ref47] 47. Lopes CMB, Zhang H, Rohacs T, Jin T, Yang J, et al. (2002) Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34: 933–944.
View Article
Google Scholar

[136] View Article

[137] Google Scholar

[ref48] 48. Fan Z, Makielski JC (1997) Anionic phospholipids activate ATP-sensitive potassium channels. J Biol Chem 272: 5388–5395.
View Article
Google Scholar

[139] View Article

[140] Google Scholar

[ref49] 49. Hibino H, Kurachi Y (2007) Distinct detergent-resistant membrane microdomains (lipid rafts) respectively harvest K(+) and water transport systems in brain astroglia. Eur J Neurosci 26: 2539–2555.
View Article
Google Scholar

[142] View Article

[143] Google Scholar

[ref50] 50. Li Y, Gao J, Lu Z, McFarland K, Shi J, et al. (2013) Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks). Proc Natl Acad Sci USA 110: 18922–18927.
View Article
Google Scholar

[145] View Article

[146] Google Scholar

[ref51] 51. Zaydman MA, Silva JR, Delaloye K, Li Y, Liang H, et al. (2013) Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening. Proc Natl Acad Sci USA 110: 13180–13185.
View Article
Google Scholar

[148] View Article

[149] Google Scholar

[ref52] 52. Hilgemann DW, Ball R (1996) Regulation of cardiac Na+,Ca2+ exchange and KATP potassium channels by PIP2. Science 273: 956–959.
View Article
Google Scholar

[151] View Article

[152] Google Scholar

[ref53] 53. Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, et al. (2007) Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116: 2913–2922.
View Article
Google Scholar

[154] View Article

[155] Google Scholar

[ref54] 54. Roura-Ferrer M, Solé L, Oliveras A, Dahan R, Bielanska J, et al. (2010) Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface targeting. J Cell Physiol 225: 692–700.
View Article
Google Scholar

[157] View Article

[158] Google Scholar

[ref55] 55. Balijepalli RC, Delisle BP, Balijepalli SY, Foell JD, Slind JK, et al. (2007) Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol. Channels (Austin) 1: 263–272.
View Article
Google Scholar

[160] View Article

[161] Google Scholar

[ref56] 56. Yarbrough TL, Lu T, Lee HC, Shibata EF (2002) Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res 90: 443–449.
View Article
Google Scholar

[163] View Article

[164] Google Scholar

[ref57] 57. Varga A, Bagossi P, Tözsér J, Peitl B, Szilvássy Z (2007) Effect of experimental hypercholesterolaemia on K+ channel alpha-subunit mRNA levels in rabbit hearts. Eur J Pharmacol 562: 130–131.
View Article
Google Scholar

[166] View Article

[167] Google Scholar

[ref58] 58. Epshtein Y, Chopra AP, Rosenhouse-Dantsker A, Kowalsky GB, Logothetis DE, et al. (2009) Identification of a C-terminus domain critical for the sensitivity of Kir2.1 to cholesterol. Proc Natl Acad Sci USA 106: 8055–8060.
View Article
Google Scholar

[169] View Article

[170] Google Scholar

[ref59] 59. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, et al. (1997) KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 96: 2778–2781.
View Article
Google Scholar

[172] View Article

[173] Google Scholar

[ref60] 60. Chouabe C, Neyroud N, Richard P, Denjoy I, Hainque B, et al. (2000) Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc Res 45: 971–980.
View Article
Google Scholar

[175] View Article

[176] Google Scholar

[ref61] 61. Jalili T, Takeishi Y, Walsh RA (1999) Signal transduction during cardiac hypertrophy: the role of G alpha q, PLC beta I, and PKC. Cardiovasc Res 44: 5–9.
View Article
Google Scholar

[178] View Article

[179] Google Scholar

Figures

Abstract

Introduction

Methods and Results

Conclusions

Introduction

Methods

Cell culture and transfection

Electrophysiology

Solutions and drugs

Molecular Modeling

Peptides.

Lipids.

Impala.

Molecule hydrophobicity and charge.

Results

R539W KCNE1-KCNQ1 is poorly sensitive to PIP2 decrease

R539W is insensitive to osmolarity

R539W is as sensitive to PKA as WT KCNE1-KCNQ1

Hypothesis on the molecular basis of the low sensitivity to PIP2 variation of R539W

R539W interacts with membrane cholesterol

Discussion

Supporting Information

File S1.

Acknowledgments

Author Contributions

References

R539W KCNE1-KCNQ1 is poorly sensitive to PIP₂ decrease

Hypothesis on the molecular basis of the low sensitivity to PIP₂ variation of R539W